Atlas Trials

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

Clinical trial NCT02948283 · COMPLETED

Trial details

NCT number
NCT02948283
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
AnemiaFatigueFeverLymphadenopathyLymphocytosisNight SweatsRecurrent Chronic Lymphocytic LeukemiaRecurrent Plasma Cell MyelomaRefractory Chronic Lymphocytic LeukemiaRefractory Plasma Cell MyelomaSplenomegalyThrombocytopenia
Start date
2017-09-05
Primary completion
2017-12-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.